Glaucoma Research Foundation Announces $2.5 Million in Grants to Cure Glaucoma
“This is the largest annual research budget in our 46-year history,” said Thomas M. Brunner, GRF President and CEO.
14-Mar-2024 7:00 AM EDT
Add to Favorites
“This is the largest annual research budget in our 46-year history,” said Thomas M. Brunner, GRF President and CEO.
14-Mar-2024 7:00 AM EDT
Add to Favorites
Attracting nearly 400 participants annually, this unique gathering unites leaders in the field of glaucoma for a full day of informative presentations, stimulating discussions, and valuable networking opportunities.
16-Jan-2024 1:05 PM EST
Add to Favorites
The Glaucoma 360 Annual Gala will include a reception, a silent art auction featuring artists with vision impairment, and a dinner to celebrate the donors, volunteers, and scientists who do so much to advance Glaucoma Research Foundation’s mission...
12-Jan-2024 12:05 PM EST
Add to Favorites
“Our goal for this catalyst meeting was to spark some new ideas and approaches to solving neurodegeneration and also to produce a white paper to capture these ideas for future publication,” said Thomas M. Brunner, President and CEO of Glaucoma...
22-Aug-2023 6:05 PM EDT
Add to Favorites
Donors, patients, the board of directors, and volunteers joined together to mark an important milestone in Glaucoma Research Foundation’s history of innovation and collaboration. Ruth Williams, MD, Vice-Chair of the Board of Directors, was the...
25-May-2023 5:05 PM EDT
Add to Favorites
Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has selected visually impaired professional triathlete Amy Dixon as keynote speaker for its 2023 Patient Summit, to be held in Long...
4-May-2023 5:55 PM EDT
Add to Favorites
Shaffer Grants provide seed funds to bold investigators whose creative projects explore promising leads and show strong potential for impact on glaucoma.
14-Mar-2023 1:30 PM EDT
Add to Favorites
The 2023 Shaffer Prize for Innovative Glaucoma Research recognizes two Shaffer Grant recipients whose projects best exemplify the pursuit of breakthrough ideas in the quest to better understand and cure glaucoma.
14-Feb-2023 5:40 PM EST
Add to Favorites
At present, the only FDA approved method of treating glaucoma is to lower eye pressure; this slows the progression of glaucomatous optic nerve damage but does not completely halt it, and certainly does not regenerate damaged nerve tissue.
16-Jun-2017 11:45 AM EDT
Stem cells may have the potential to protect the optic nerve from further damage and slow the progression of vision loss due to glaucoma. Stem cells may also have the potential to replace ocular tissues that have degenerated in eyes with glaucoma.
17-Mar-2016 9:05 AM EDT
The Glaucoma Research Foundation mission is to cure glaucoma and restore vision through innovative research.